Incyte Corp. (INCY)
124.41
-2.34
(-1.85%)
USD |
NASDAQ |
Sep 08, 15:59
124.41
0.00 (0.00%)
After-Hours: 20:00
Incyte Market Cap : 25.00B for Sept. 8, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 04, 2026 | 25.47B |
| September 03, 2026 | 25.73B |
| September 02, 2026 | 25.89B |
| September 01, 2026 | 25.12B |
| August 31, 2026 | 24.76B |
| August 28, 2026 | 25.00B |
| August 27, 2026 | 25.67B |
| August 26, 2026 | 25.75B |
| August 25, 2026 | 26.07B |
| August 24, 2026 | 25.72B |
| August 21, 2026 | 25.69B |
| August 20, 2026 | 25.57B |
| August 19, 2026 | 25.82B |
| August 18, 2026 | 24.81B |
| August 17, 2026 | 24.82B |
| August 14, 2026 | 24.15B |
| August 13, 2026 | 24.22B |
| August 12, 2026 | 24.27B |
| August 11, 2026 | 24.33B |
| August 10, 2026 | 24.43B |
| August 07, 2026 | 24.23B |
| August 06, 2026 | 23.79B |
| August 05, 2026 | 24.08B |
| August 04, 2026 | 24.24B |
| August 03, 2026 | 23.80B |
| Date | Value |
|---|---|
| July 31, 2026 | 24.02B |
| July 30, 2026 | 24.72B |
| July 29, 2026 | 25.54B |
| July 28, 2026 | 26.11B |
| July 27, 2026 | 23.89B |
| July 24, 2026 | 23.65B |
| July 23, 2026 | 23.33B |
| July 22, 2026 | 23.15B |
| July 21, 2026 | 23.47B |
| July 20, 2026 | 23.12B |
| July 17, 2026 | 23.44B |
| July 16, 2026 | 23.32B |
| July 15, 2026 | 23.01B |
| July 14, 2026 | 22.97B |
| July 13, 2026 | 22.84B |
| July 10, 2026 | 23.34B |
| July 09, 2026 | 23.70B |
| July 08, 2026 | 23.45B |
| July 07, 2026 | 23.60B |
| July 06, 2026 | 23.12B |
| July 02, 2026 | 23.37B |
| July 01, 2026 | 22.76B |
| June 30, 2026 | 22.67B |
| June 29, 2026 | 22.93B |
| June 26, 2026 | 22.74B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Mirum Pharmaceuticals, Inc. | 6.448B |
| Regeneron Pharmaceuticals, Inc. | 83.76B |
| Eli Lilly & Co. | 1.058T |
| AbbVie, Inc. | 439.42B |
| Biogen, Inc. | 31.38B |
Market Cap Related Metrics
| PE Ratio | 15.86 |
| PS Ratio | 4.389 |
| PEG Ratio | 0.2023 |
| Price to Book Value | 3.941 |
| Price to Free Cash Flow | 13.51 |
| Price | 124.41 |
| Earnings Yield | 6.31% |
| PEGY Ratio | 0.2023 |
| Operating PE Ratio | 13.88 |
| Normalized PE Ratio | 15.61 |